mRNA Vaccine Manufacturing Comes to Africa
BioSpace
SEPTEMBER 26, 2023
The COVID-19 pandemic highlighted a need for local production of vaccines. Now, German pharma company BioNTech has said it will start manufacturing vaccines in Africa.
World’s Top 10 Pharma Companies (By 2023 Revenue)
XTalks
MAY 29, 2024
The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharma companies in 2024 based on 2023 revenue.
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Covid vaccine profits and the strain on supply channels
World of DTC Marketing
JANUARY 8, 2021
SUMMARY: Pfizer and Moderna will sell $28 billion of Covid-19 vaccines this year. Pharma companies will make an estimated $40 billion on the global COVID-19 vaccine market this year, which will be split between Johnson & Johnson, AstraZeneca, Novavax, and others. So far the winners are Pfizer and Moderna.
Vaccination 
266
266 
BioNTech mobile mRNA vaccine labs reach Rwanda
Medical Xpress
MARCH 13, 2023
Six mobile vaccine production units by German pharma company BioNTech arrived in Rwanda on Monday, the first such shipments to Africa as the continent seeks to boost mRNA vaccine manufacturing.
Vaccination 72
72 
COVID 19 vaccine means big money and greed
World of DTC Marketing
JULY 28, 2020
QUICK READ : Pharma had a chance to earn some goodwill with a very skeptical public but it’s become obvious that the rush to develop a vaccine is about profit, executive stock, and Wall Street despite potential huge investments from the government. Moderna, a 10-year-old vaccine developer based in Cambridge, Mass.,
Vaccination 181
181 
Prefilled syringes and vaccines: Optimising parenteral packaging for the next pandemic
Pharmaceutical Technology
NOVEMBER 15, 2022
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”.
Packaging 130
130 
UK Pharma Company Scancell Selects COVID-19 Vaccine for Clinical Trials | 2020-12-21
The Pharma Data
DECEMBER 20, 2020
UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.
Report suggests UK’s national vaccine facility is on the block
pharmaphorum
NOVEMBER 29, 2021
The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale. It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.
Vaccination 103
103 
Moderna unveils $500m plan for African vaccine facility
pharmaphorum
OCTOBER 7, 2021
Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. of Africans have been fully vaccinated against COVID-19, and just 15 African nations have met the agency’s objective of 10% coverage.
Vaccination 98
98 
The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’
pharmaphorum
DECEMBER 16, 2022
Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Further, with a pandemic treaty in development, there are reasons to believe that many countries and the WHO want to see a more equitable distribution of medical products for future pandemics.
Vaccination 96
96 
Why was R&D productivity up in 2021?
pharmaphorum
FEBRUARY 14, 2022
A recent report has found that R&D productivity rose vertiginously during 2021, but how much of this was organic and how much can be attributed to the pandemic? The pandemic also saw a reduction in the overall development cycle of a product, which has been growing in recent years. In 2020, the development cycle averaged 7.14
Production 98
98 
Cancer vaccines: providing the edge in oncology
pharmaphorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment.
Vaccination 133
133 
Cyberattack targets EMA, hacks COVID-19 vaccine data
pharmaphorum
DECEMBER 10, 2020
The European Medicines Agency (EMA) says it suffered a cyberattack, with documents relating to a Pfizer and BioNTech’s COVID-19 vaccine accessed. Shortly after however BioNTech confirmed that documents submitted as part of its marketing application for coronavirus vaccine BNT-162b had been accessed by the hackers.
Vaccination 109
109 
COVID prompts another milestone, as India clears first DNA vaccine
pharmaphorum
AUGUST 23, 2021
The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. Proponents of the approach claim that DNA vaccines may have advantages over other technologies like mRNA.
DNA 98
98 
Vaccines upstart Curevo has designs on blockbuster GSK franchise
pharmaphorum
FEBRUARY 14, 2022
Seattle, US vaccine startup Curevo has raised $60 million in first-round financing that it says will be used to run head-to-head trials of its experimental shingles vaccines CRV-101 and GlaxoSmithKline’s market-leading Shingrix. The biotech has been looking for a development partner for the shot as a chickenpox vaccine.
Vaccination 52
52 
The hypocrisy of big pharma
World of DTC Marketing
SEPTEMBER 23, 2021
SUMMARY: Pfizer will earn over 26 billion dollars from their COVID vaccine, while Moderna and J&J also look to their vaccines for more profit dollars. Here is his rationale: “ When we asked the Pfizer colleagues to develop a Covid-19 vaccine in l ess than a year, you did. trillion social spending package.
Vaccination 214
214 
Preventing the next pandemic: Infrastructure and global equity
pharmaphorum
JULY 15, 2022
In the final piece of a three-part series, Ben Hargreaves explores how manufacturing infrastructure was rapidly built up to the required capacity to ensure sufficient supply of COVID-19 vaccines, and what still remains to be done to improve vaccine equity globally. All angles.
Vaccination 113
113 
How Berlinger’s climate-focused innovation is helping to reduce, remove and offset emissions from the pharmaceutical supply
Pharmaceutical Technology
SEPTEMBER 16, 2022
And despite the recent pandemic that forced the industry to develop and deliver treatments and vaccines all over the world, the issue of reducing emissions has remained high on industry leaders’ agendas. Berlinger has positioned itself as a primary enabler of pharma companies and their supply chain partners in rethinking the cold chain.
Pharma Companies 130
130 
ODAIA wins $25m funding to boost commercial insights platform for pharma
Pharmaceutical Technology
MAY 2, 2023
ODAIA will use the latest investment to further advance its artificial intelligence (AI)-powered product offerings, allowing the pharma companies to deliver various life changing therapies to the patients faster.
Life Science 147
147 
Arecor hopes London stock market float will raise profile of insulin products
pharmaphorum
MAY 17, 2021
Based in Cambridge, Arecor has proprietary formulation technology and plans to licence out drugs to big pharma companies, looking for milestone payments and royalties as they progress through the development process to launch. The initial therapeutic focus is diabetes, with three insulin-based products in development.
Insulin 52
52 
HCP’s use of social media: the good and the not so good
World of DTC Marketing
AUGUST 9, 2021
86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs. Doximity was flagged for having anti-vaccine information. HCPs don’t necessarily want pharma trying to sell products via social media.
Nurses 294
294 
CMO Moves: Regulatory catalysts for drug manufacturing-April
Pharmaceutical Technology
JULY 14, 2022
In this ongoing series , we put a spotlight on contracts between pharma companies and contract manufacturing organizations (CMOs). This analysis is based on the GlobalData Pharma Intelligence Center’s Deals database and PharmSource reports. Covid-19 vaccines stay in the spotlight. Consequential FDA and EMA decisions.
Manufacturing 130
130 
Injectable opportunities for CMOs despite internal capacity of big pharma sponsors
Pharmaceutical Technology
AUGUST 16, 2022
Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Why do large and mega-cap sponsors outsource?
Gene Therapy 162
162 
And so pharma profiteers again
World of DTC Marketing
APRIL 14, 2021
QUICK READ: Pfizer has already announced a price increase to the EU for their Covid Vaccine. The company announced last month that it expects to make $15bn (£10.9bn) off its coronavirus vaccine this year based on current deals. Drug companies on average spend about 20% of all their sales revenue on R&D.
Pharma Companies 191
191 
Edelman Trust Barometer raises questions
World of DTC Marketing
MARCH 11, 2022
3hree: Those with higher levels of trust in healthcare are more likely to be proactive about their general health, vaccinated against COVID-19, supportive of public health measures over personal freedom, and accepting of changing recommendations from healthcare officials than are low-trusting respondents.
Pharma Companies 212
212 
The immediate future of DTC
World of DTC Marketing
DECEMBER 28, 2020
Once vaccination levels reach critical mass, people will once again return to their physician’s offices. Let’s be clear about pharma product websites. In short, online health seekers aren’t finding compelling reasons to ask for your product on your website.
Doctors 296
296 
Health misinformation online abounds
World of DTC Marketing
NOVEMBER 24, 2020
Pfizer’s ad in newspapers yesterday was a good start to trying to earn back trust but unfortunately the misinformation about vaccine candidates is already starting to gather momentum. Earning trust is not done through one act or with one product; it’s done through a consistent emphasis on transparency.
Scientist 277
277 
In The Global Race For The COVID-19 Vaccine, India Stands As A Strong Player
Delveinsight
JULY 29, 2020
Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus.
Vaccination 62
62 
The drug industry continues to dare regulation
World of DTC Marketing
FEBRUARY 21, 2022
Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. Reportedly, the cost of production for molnupiravir stands at about $17.74. Pfizer’s Paxlovid currently costs about $530 for a five-day course of the treatment. costs about $700. spending annually.
Regulation 218
218 
The future of pharma depends on its employees
World of DTC Marketing
JANUARY 7, 2021
Some within pharma has worked at so many jobs their resume reads like a list of pharma companies. These people tend to want titles of importance and come across as someone who would politically fit within a company. Why hasn’t Pfizer offered some help in vaccine distribution?
Pharma Companies 215
215 
Keeping tabs on Covid-19: Iceni Diagnostics creates new virus detection device and the RDIF announce its vaccine is more than 95 per cent efficient
The Pharma Data
NOVEMBER 27, 2020
Vaccine development to cure coronavirus is at an all-time high after Pfizer and BioNTech announced they had success with a possible vaccine candidate. One dose of the Sputnik V vaccine will cost less than $10 for international markets.
Vaccination 52
52 
Pharma is hiring
World of DTC Marketing
AUGUST 13, 2020
IN BRIEF: Pharma companies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. In correct information about vaccines and other treatments was rampant.
Branding 223
223 
A HUGE opportunity for pharma websites
World of DTC Marketing
AUGUST 10, 2021
SUMMARY : Falsehoods have been shown to spread faster and farther than accurate information, and research suggests that misinformation can have negative effects in the real world, such as amplifying controversy about vaccines and propagating unproven cancer treatments. Engagement within pharma websites is completely different from CPGs.
Production 180
180 
Keeping tabs on Covid-19: UK approves safety of Pfizer and BioNTech’s Covid-19 vaccine
The Pharma Data
DECEMBER 4, 2020
After an incredible milestone for science, this week we bring our readers news from Pfizer and BioNTech on the promise of a Covid-19 vaccine result. Pfizer and BioNTech achieve first authorization use for their Covid-19 vaccine in the UK. Our aim is to bring a safe and effective vaccine upon approval to the people who need it.
Vaccination 52
52 
Projections on pharma digital ad spending wrong
World of DTC Marketing
OCTOBER 19, 2020
While some media outlets are saying that a COVID-19 vaccine can help pharma’s reputation I believe that is wishful thinking. We are already seeing a drop in the number of people who are willing to get a COVID-19 vaccination and until trust can be re-established with the FDA and the CDC I expect that number to remain high.
Vaccination 180
180 
Pharma’s climate change vulnerability and opportunity
pharmaphorum
SEPTEMBER 9, 2022
Rising global temperatures will, for example, enhance the spread of mosquito-borne diseases like malaria and Zika, increasing the need for effective vaccines. Just as in the wake of COVID-19, the world will look to pharma to fulfil its public health needs. In 2019, the pharmaceutical industry produced 48.55 Vulnerability .
Production 104
104 
Should we be worried about pharma’s supply chain?
World of DTC Marketing
APRIL 12, 2021
A blood-thinning agent, heparin, had been adulterated due to the product license holder (Baxter) procuring a toxic substance that had been illegally substituted for the genuine registered material. The adulterated product was found to have caused nine patient deaths and 574 serious adverse events (SAEs).
Generic Drugs 187
187 
Telehealth concerns rise
World of DTC Marketing
MARCH 11, 2021
What can pharma do? Pharma companies need to work closely with doctors to remind patients that telehelath is not always a replacement for a physician-patient consultation. Pharma companies should be posting content on every product site to remind patients that not all health problems can be diagnosed via a computer screen.
Doctors 180
180 
What do future healthcare CEOs look like?
World of DTC Marketing
APRIL 7, 2021
Pharma, PBM, and health insurance CEOs earn hundreds of millions of dollars to do one thing; make their companies a lot of money. Already vaccine makers are saying that we may need a Covid Vaccine booster shot every year even though there is no long term data as of yet. Walgreens Boots Alliance, Stefano Pessina — $19.2
Vaccination 162
162 
Amnesty says COVID jab producers are causing human rights crisis
pharmaphorum
SEPTEMBER 22, 2021
Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies of for not agreeing to waive their intellectual property rights and share the technology behind them. billion doses administered worldwide, just 0.3% billion doses administered worldwide, just 0.3%
Vaccination 104
104 
As pharma abandons the antibiotic market patients are at risk
World of DTC Marketing
MARCH 3, 2021
He really saw his products as a way to help people manage information overload. The pharma industry has helped many of us live better lives, but as one of the most profitable industries globally, they need to use some of this profits to help develop new antibiotics, and Wall Street be damned!
Marketing 174
174 
Pharma has a long way to go
World of DTC Marketing
DECEMBER 21, 2020
I’m hoping a new leader can restore the CDC and FDA’s trust and that the nationwide vaccination problem can proceed, but there are bigger issues. Long after COVID is a bad memory, the pharma industry will still be making more and more mistakes in the name of profits. The media loves to pick on pharma companies.
Pharma Companies 180
180 
Top 20 global biopharma companies report 5.4% growth
Drug Discovery World
FEBRUARY 7, 2023
According to analytics company GlobalData, 11 companies indicated double-digit growth, with four companies – Merck & Co (45.3%), Vertex Pharmaceuticals (32.8%), Eli Lilly (31.6%), and AstraZeneca (21.5%) – reporting more than 20% YoY growth in market capitalisation. The post Top 20 global biopharma companies report 5.4%
Sales 52
52 
This week in drug discovery (11-15 September)
Drug Discovery World
SEPTEMBER 15, 2023
The headlines: Pharma must embrace an AI future says new report Artificial intelligence (AI) technology has the potential to revolutionise drug discovery and pharma companies need to make plans for a future in which AI is frequently utilised in research, says ResearchAndMarkets.com.
Drugs 52
52 
Let's personalize your content